An invitation to meet George Estreich at the Center for Genetics and Society on Monday, June 3
By Flagged
| 05. 21. 2013
Please join us at the CGS office on Monday June 3 at 4:30 pm for a conversation with award-winning author George Estreich.
The Shape of the Eye, George’s family memoir about his daughter Laura, who has Down syndrome, has just been released in paperback. It’s getting rave reviews everywhere from the CGS blog Biopolitical Times, to parenting sites, to People magazine.
In a new afterword and in a series of amazing posts at Biopolitical Times (1, 2, and 3), George reflects on how the new prenatal gene tests are being marketed, what those marketing messages tell us about perceptions of disability and “normality,” and what’s in store as full-genome fetal testing develops. We are honored to have published those essays, as well as George’s "Of Monsters and Men," about The Amazing Spider-Man, and "On Vampires and Chromosomes," about the Twilight books.
We’ll have time after George’s remarks for discussing all of this, and for wine and light refreshments.
Please RSVP to mdarnovsky[AT]geneticsandsociety[DOT]org.
WHO: George Estreich, author of The Shape...
Related Articles
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...